Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026)
Nuwellis (NUWE) reported Income from Continuing Operations of 4541000.0 for Q1 2026, down 50.66% on a YoY basis from 9204151.98 in Q1 2025, and down 130.04% quarter-over-quarter from 15118000.0 in Q4 2025.
Nuwellis (NUWE) Income from Continuing Operations (2011 - 2026) Analysis & Trends
Nuwellis has reported Income from Continuing Operations for 16 years, with the latest figure at 4541000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 50.66% year-over-year to 4541000.0; the trailing twelve-month figure through Mar 2026 stood at 1508000.0 (up 84.73% YoY), and the FY2025 full-year result was 19000.0, up 100.17% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 4541000.0, down from 15118000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 15118000.0 in Q4 2025, with the low at 12553000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 920764.71 across 5 years, with a median of 3870000.0 in 2022.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations slumped 110.14% — and 2025, when it surged 1112.59%.
- Nuwellis' Income from Continuing Operations stood at 12664000.0 in 2022, then climbed by 16.27% to 14724000.0 in 2023, then tumbled by 110.14% to 1493000.0 in 2024, then surged by 1112.59% to 15118000.0 in 2025, then tumbled by 130.04% to 4541000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 4541000.0 (Q1 2026), 15118000.0 (Q4 2025), and 468000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Nuwellis | 279,710.00 | -1.80 Mn | 1.68 Mn | -4.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.54 Mn |
| Dec 31, 2025 | 15.12 Mn |
| Sep 30, 2025 | 468,000.00 |
| Jun 30, 2025 | -12.55 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | 2.36 Mn |
| Jun 30, 2024 | -7.73 Mn |
| Mar 31, 2024 | -4.33 Mn |
| Dec 31, 2023 | 14.72 Mn |
| Sep 30, 2023 | -3.37 Mn |
| Jun 30, 2023 | -4.85 Mn |
| Mar 31, 2023 | -6.49 Mn |
| Dec 31, 2022 | 12.66 Mn |
| Sep 30, 2022 | -3.87 Mn |
| Jun 30, 2022 | -4.29 Mn |
| Mar 31, 2022 | -4.47 Mn |
| Dec 31, 2021 | 15.25 Mn |
| Sep 30, 2021 | -5.27 Mn |
| Jun 30, 2021 | -4.73 Mn |